CI vs CYTK · P/E 2.4, rev $274.90B vs rev $18.5M
Cigna Corp (CI) versus Cytokinetics Inc (CYTK) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported CYTK revenue for 2024-12-31 was $18.5M. Net income was -$589.5M. Revenue was up 145.3% from 2023-12-31 to 2024-12-31. CYTK currently screens at market cap $4.05B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. CYTK currently screens at market cap $4.05B.
Not investment advice. Open the CI and CYTK stock pages for the full models.
Not investment advice.